MTOR and glioblastoma: In a contradictory way, another approach to GBM treatment could consist in targeting the autophagy inhibitor mTOR.42, 103 Indeed, dysregulation of the PI3K/Akt/mTOR signaling pathway is common in human cancers, inducing uncontrolled cell proliferation, which can be targeted by rapamycin analogs.